- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The Daily Mail UK reported that a scientists may have found a way to turn skin cells into healthy pancreatic cells, replacing the damaged cells found in type 1 diabetes.
The Daily Mail UK reported that a scientists may have found a way to turn skin cells into healthy pancreatic cells, replacing the damaged cells found in type 1 diabetes.
According to the Daily Mail UK:
The researchers, from the Gladstone Institutes and the University of California, San Francisco, found the right recipe to turn human skin cells into healthy, fully-functional versions of the pancreatic beta cells that are damaged in diabetes.
Anna Morris, of the charity Diabetes UK, said:
The generation of insulin-producing pancreatic cells in the lab, that could be successfully transplanted into people with diabetes, is a very exciting area of research that could revolutionise the future treatment of the condition.
The results of this particular early-stage laboratory study, which has been carried out in mice, are very promising and we look forward to future investigations testing whether this method could be reproduced in humans, and ultimately developed as a treatment for diabetes.
It’s very exciting that research in this area is moving forward.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â